Shenzhen Neptunus Interlong Bio-Technique Co Ltd

08329

Company Profile

  • Business description

    Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.

  • Contact

    979 King’s Road
    43rd Floor, One Taikoo Place
    Quarry Bay
    Hong Kong
    HKG

    https://www.interlong.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,474

Stocks News & Analysis

stocks

Navigating the ASX dividend landscape in 2026

Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks

Meta stock has struggled amid AI spending concerns. Is it a buy?

Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks

Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth

We think Netflix stock is moderately overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,153.306.80-0.07%
CAC 408,069.176.590.08%
DAX 4024,560.98142.14-0.58%
Dow JONES (US)49,072.24583.651.20%
FTSE 10010,138.0911.310.11%
HKSE26,592.517.450.03%
NASDAQ23,224.82270.501.18%
Nikkei 22553,760.85986.211.87%
NZX 50 Index13,514.7359.20-0.44%
S&P 5006,873.7776.911.13%
S&P/ASX 2008,829.806.10-0.07%
SSE Composite Index4,123.916.970.17%

Market Movers